Empirical Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Empirical Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$723K	Hold	5,657	–	–	0.19%	145
2025 Q4	$690K	Hold	5,657	–	–	0.19%	149
2025 Q3	$567K	Sell	5,657 -1,200	-18%	-$108K	0.16%	205
2025 Q2	$569K	Hold	6,857	–	–	0.18%	188
2025 Q1	$556K	Sell	6,857 -2,454	-26%	-$219K	0.19%	161
2024 Q4	$620K	Sell	9,311 -630	-6%	-$61K	0.21%	140
2024 Q3	$742K	Sell	9,941 -39	-0.4%	-$3.83K	0.26%	111
2024 Q2	$700K	Buy	9,980 +2,346	+31%	+$210K	0.26%	108
2024 Q1	$724K	Buy	+7,634	New	+$708K	0.35%	78
2023 Q1	–	Sell	-10,883	Closed	-$903	–	204
2022 Q4	$903	Buy	+10,883	New	+$881K	﹤0.01%	159

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Empirical Asset Management's XBI Position: Q1 2026 in Review

Empirical Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 5,657 shares worth $723K. The position accounts for 0.19% of the portfolio, ranked #145.

Empirical Asset Management first reported a position in XBI in Q4 2022 and has held it in 10 quarters since. The position peaked at $742K in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Empirical Asset Management held 5,657 shares of State Street SPDR S&P Biotech ETF worth $723K as of Q1 2026.
Empirical Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.19% of Empirical Asset Management's portfolio in Q1 2026, its #145 holding.
Empirical Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 10 quarters since.
Empirical Asset Management's State Street SPDR S&P Biotech ETF position peaked at $742K in Q3 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Empirical Asset Management's 13F filing for Q1 2026, filed 11 May 2026.